HomeInvestors HealthOrganon downgraded, Amneal upgraded as J.P. Morgan reviews specialty pharma

Organon downgraded, Amneal upgraded as J.P. Morgan reviews specialty pharma

525-5250815_gold-ball-free-png-gold-ball-png-clipart

September 6, 2024

Organon downgraded, Amneal upgraded as J.P. Morgan reviews specialty pharma

Source link

Previous article

Why Zscaler Stock Was Sliding This Week

Next article

Is Nvidia a Safe Stock to Own During a Recession?

Investors Health Image

latest articles

explore more

LEAVE A REPLY Cancel reply

Please enter your comment!

Please enter your name here

You have entered an incorrect email address!

Please enter your email address here